Free radicals, antioxidants in disease and health

International Journal of Biomedical Science

Volumn 4, Issue 2, 2008, Pages 89-96

  Pham Huy, Lien Ai ^a   He, Hua ^b   Pham Huy, Chuong ^c  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b CHINA PHARMACEUTICAL UNIVERSITY   (China)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Antioxiants; Beneficial effects; Deleterious effects; Diseases; Free radicals; Health; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ARGININE; ARSENIC; ASCORBIC ACID; BETA CAROTENE; BLEOMYCIN; CADMIUM; CHROMIUM; CIGARETTE SMOKE; COBALT; COPPER; CYCLOSPORIN; FLAVONOID; FREE RADICAL; GENTAMICIN; HEAVY METAL; IRON; LEAD; LYCOPENE; MERCURY; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OXIDIZING AGENT; SELENIUM; TACROLIMUS; TRANSITION ELEMENT; UBIDECARENONE; UNINDEXED DRUG; VINBLASTINE;

AGING; ANTIOXIDANT ACTIVITY; AUTOIMMUNE DISEASE; CARCINOGENICITY; CARDIOVASCULAR DISEASE; CATABOLISM; CATARACT; CELL ACTIVITY; CELL METABOLISM; CHRONIC DISEASE; CLINICAL TRIAL; DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; DRUG USE; EYE DISEASE; HUMAN; INTRAUTERINE GROWTH RETARDATION; KIDNEY DISEASE; LOW DRUG DOSE; LUNG DISEASE; NEOPLASM; NEPHROTOXICITY; NEUROLOGIC DISEASE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; POLLUTION; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RADIATION; REVIEW; RHEUMATOID ARTHRITIS; SELENIUM DEFICIENCY; TAXONOMY;

EID: 57849121240     PISSN: 15509702     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. 4th ed. Oxford, UK: Clarendon Press; 2007.
2. Bahorun T, Soobrattee MA, Luximon-Ramma V, Aruoma OI. Free radicals and antioxidants in cardiovascular health and disease. Internet J Med Update 2006;1:1-17
3. Valko M, Izakovic M , Mazur M, Rhodes CJ, Telser J. Role of oxygen radicals in DNA damage and cancer incidence. Mol Cell Biochem 2004, 266: 37-56.
4. Valko M, Leibfritz D, Moncola J, Cronin MD, et al. Free radicals and antioxidants in normal physiological functions and human disease. Review. Int J Biochem Cell Biol 2007;39:44-84.
5. Droge W. Free radicals in the physiological control of cell function. Review. Physiol Rev. 2002;82:47-95.
6. Willcox JK, Ash SL, Catignani GL. Antioxidants and prevention of chronic disease. Review. Crit Rev Food Sci Nutr 2004;44:275-95.
7. Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 2007;87:315-424.
8. Genestra M. Oxyl radicals, redox-sensitive signalling cascades and antioxidants. Review. Cell Signal. 2007;19:1807-19
9. Halliwell B. Biochemistry of oxidative stress. Biochem Soc Trans. 2007;35:1147-50.
10. Young I, Woodside J. Antioxidants in health and disease. J Clin Pathol. 2001;54:176-86.
11. Valko M, Rhodes CJ, Moncol J, Izakovic M, et al. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Mini-review. Chem Biol Interact. 2006;160: 1-40.
12. Valko M, Morris H, Cronin MTD. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12:1161-208.
13. Parthasarathy S, Santanam N, Ramachandran S, Meilhac O. Oxidants and antioxidants in atherogenesis: an appraisal. J Lipid Res. 1999; 40:2143-57.
14. Frei B. Reactive oxygen species and antioxidant vitamins. Linus Pauling Institute. Oregon State University. 1947, http://lpi.oregonstate.edu/ f-w97/reactive.html
15. Chatterjee M, Saluja R, Kanneganti S, et al. Biochemical and molecular evaluation of neutrophil NOS in spontaneously hypertensive rats. Cell Mol Biol. 2007;53:84-93.
16. Ceriello A. Possible role of oxidative stress in the pathogenesis of hypertension. Review. Diabetes Care. 2008 ;31(Suppl 2):S181-4.
17. Halliwell B. Role of free radicals in neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 2001; 18: 685-716.
18. Singh RP, Sharad S, Kapur S. Free radicals and oxidative stress in neurodegenerative diseases: Relevance of Dietary Antioxidants. JIACM, 2004;5:218-25.
19. Christen Y. Oxidative stress and Alzheimer disease. Am J Clin Nutr 2000;71: 621S-9S.
20. Butterfield DA. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review. Free Radic Res 2002;36:1307-13.
21. Caramori G, Papi A. Oxidants and asthma. Review. Thorax 2004; 59:170-3
22. Guo RF, Ward PA. Role of oxidants in lung injury during sepsis. Antioxid Redox Signal. 2007;9:1991-2002.
23. Hoshino Y, Mishima M. Antioxidants & redox signaling redox-based therapeutics for lung diseases. Antioxid Redox Signal. 2008; 10:701-4.
24. MacNee W. Oxidative stress and lung inflammation in airways disease. Eur J Pharmacol 2001;429:195-207.
25. Walston J, Xue Q, Scmba RD, Ferrucci L, et al. Serum antioxidants, inflammation, and total mortality in older women. Am J Epidemiol 2006; 163:18-26.
26. Mahajan A, Tandon VR. Antioxidants and rheumatoid arthritis. J Indian Rheumatol Ass. 2004;12:139-42.
27. Galle J. Oxidative stress in chronic renal failure. Nephrol Dial Transplant 2001;16:2135-42.
28. Sadeg N, Pham-Huy C, Martin C, Warnet JM, Claude JR. Effect of cyclosporin A and its metabolites and analogs on lipid peroxidation in rabbit renal microsomes. Drug Chem Toxicol 1993;16:165-74.
29. Massicot F, Martin C, Dutertre-Catella H, Ellouk-Achard S, Pham-Huy C, et al. Modulation of energy status and cytotoxicity induced by FK506 and cyclosporin A in a renal epithelial cell line. Arch Toxicol 1997; 71:529-31.
30. Massicot F, Lamouri A, Martin C, Pham-Huy C, et al. Preventive effects of two PAF-antagonists, PMS 536 and PMS 549, on cyclosporin-induced LLC-PK1 oxidative injury. J Lipid Mediat Cell Signal 1997;15: 203-14.
31. Santosa S, Jones, PJ. Oxidative stress in ocular disease: does lutein play a protective role? Can Med Ass J (CMAJ) 2005;173: 861-2.
32. Meyer CH, Sekundo W. Nutritional supplementation to prevent cataract formation. Dev Ophthalmol 2005;38:103-19.
33. Beatty S, Koh HH, Phil M, Henson D, Boulton M. The Role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol 2000;45: 115-34.
34. Myatt L. Placental adaptive responses and fetal programming. J Physiol 2006;572:25-30.
35. Hracsko Z, Orvos H, Novak Z, Pal A, Varga IS. Evaluation of oxidative stress markers in neonates with intra-uterine growth retardation. Redox Rep 2008;13:11-6.
36. Biri A, Bozkurt N, Turp, A et al. Role of oxidative stress in intrauterine growth restriction. Gynecol Obstet Invest. 2007; 64:187-92.
37. Braekke K, Harsem NK, Staff AC. Oxidative stress and antioxidant status in fetal circulation in preeclampsia. Pediatr Res 2006;60:560-4.
38. Donaldson MS. Nutrition and cancer: A review of the evidence for an anti-cancer diet. Nutr J 2004;3:19-25.
39. Nguyen LA, He H, Pham-Huy C. Chiral drugs. An overview. Int J Biomed Sci (IJBS) 2006;2:85-100.
40. Mayo Clinic Medical Information. Drugs and supplements. Vitamin E. 2005, http://www.mayoclinic.com/health/vitamin-e/NS_patient-vitamin-e.
41. Miller ER, Pastor-Barriuso R, Dalal D, et al. Meta-analysis: high-dosage Vitamin E supplementation may increase all-cause mortality, Ann Intern Med 2005;142:37-46.
42. Li Y, Schellhorn HE. New developments and novel therapeutic perspectives for vitamin C. Critical Review. J Nutr 2007;137:2171-84.
43. Naidu AK. Vitamin C in human health and disease is still a mystery? An overview. Nutr J 2003;2:1-10.
44. Mayo Clinic Medical Information. Drugs and supplements. Beta-carotene. 2005, http://www.mayoclinic.com/health/beta-carotene/ NS_patient-betacarotene
45. Seren S, Lieberman R, Bayraktar UD, Heath E, et al. Lycopene in cancer prevention and treatment. Review. Am J Ther. 2008;15:66-81.
46. Dahan K, Fennal M, Kumar NB. Lycopene in the prevention of prostate cancer. J Soc Integr Oncol. 2008;6:29-36.
47. Pham-Huy C., Nguyen P., Marchand V., et al. Selenium and tobacco smoke tars: In vitro effects on different immunocompetent cells. Toxicology 2001;164:111-2. Presented in International Congress of Toxicology XI, Brisbane (Australia), 7-12 July 2001.
48. Higdon J, Drake VJ, Whanger PD. Selenium. Linus Pauling Institute. Oregon State University. Micronutrient Information Center. 2007, http://lpi.oregonstate.edu/infocenter/minerals/selenium/
49. Miller AL. Antioxidant Flavonoids: Structure, Function and Clinical Usage. Alt Med Rev 1996;1:103-11.
50. Hanneken A, Lin FF, Johnson J, Maher P. Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death. Invest Ophthalmol Vis Sci 2006;47:3164-77.
51. Pham-Huy NLA, He H and Pham-Huy C. Green tea and health. An overview. J Food Agric Environ (JFAE) 2008;6:6-13.
52. University of Maryland Medical Center . Omega-3 fatty acids. Overview. 2007. http://www.umm.edu/altmed/articles/omega-3-000316.htm
53. Logan AC. Omega-3 fatty acids and major depression: A primer for the mental health professional. Review. Lipids Health Dis. 2004;3: 25-33.
54. Barbul A, Uliyargoli A. Use of exogenous arginine in multiple organ dysfunction syndrome and sepsis. Crit Care Med 2007;35:S564-7.
55. Dhanasekaran M, Ran J. The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus. Curr Neurovasc Res 2005;2:447-59.
56. Maharaj DS, Glass BD, Dava S. Melatonin: new places in therapy. Biosci Rep 2007;27:299-320.
57. Fusco D, Colloca G, Lo Monaco MR and Cesari M. Effects of antioxidant supplementation on the aging process. Review. Clin Interv Aging 2007; 2:377-87.
58. Nitta H, Kinoyama M, Watanabe A, Shirao K et al. Effects of nutritional supplementation with antioxidant vitamins and minerals and fist oil on antioxidant status and psychosocial stress in smokers: an open trial. Clin Exp Med. 2007;7:179-83.
59. Baedia A, Tleyjeh IM, Cerhan JR, Sood AK, et al. Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis. Review. Mayo Clin Proc. 2008; 83:23-34.